FXYD2 and peripheral nerve lesion: Indeed, after peripheral nerve lesions or inflammation, FXYD2 has been shown to reduce the activity of this pump and to allow persistent neuronal hyperexcitability notably of the so-called non-peptidergic IB4-positive nociceptive population.